Merus N.V.
Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guidelines: http://bit.ly/36c
253 employees · est. 2003 · Utrecht, The Netherlands
Agenus is the older company (1994 vs 2003).
Side-by-Side Comparison
| Metric | Agenus | Merus N.V. |
|---|---|---|
| Founded | ||
| Founded | 1994 older | 2003 |
| Headquarters | ||
| Headquarters | Lexington, United States | Utrecht, The Netherlands |
| Employees | ||
| Employees | 291 | 253 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Medical Devices | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Debt | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $346.14M | $1.04B |
| Funding Rounds | ||
| Funding Rounds | 8 | 11 |
| Services | ||
| Services | Not tracked yet | Development of Cancer Treatments, Clinical Trials Management, Research and Development in Biotechnology, Multiclonics Therapeutics |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer Patients, Healthcare Providers, Medical Researchers, Pharmaceutical Industry |
| Taxonomy | ||
| Taxonomy | Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors, Immunotherapy, Cell Therapy, Antibodies, GMP Manufacturing | Biclonics®, Bispecific Antibody Therapeutics, Antibody-based Biopharmaceuticals, Oligoclonics Technology, Immuno-oncology, Cancer Treatment, Antibody Engineering, Tumor Cell Inhibition, Immune System Activation, Biomarker Development, Clinical Trials, Oncology Research, Therapeutic Antibodies, Antibody Discovery, Cell Biology |
| Website | ||
| Website | agenusbio.com | merus.nl |
About Agenus
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company, founded in 1994 and headquartered in Lexington, MA, aims to expand patient populations benefiting from cancer immunotherapy through combination app...
About Merus N.V.
Merus N.V., a biotechnology firm founded in 2003, is headquartered in The Netherlands. The company is at the forefront of developing innovative oncology solutions using its proprietary Biclonics® bispecific antibody therapeutics. This pioneering approach enables simultaneous multi-targeted tumor att...
We will tell you when either one moves
BounceWatch watches Agenus and Merus N.V. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Agenus and Merus N.V. — by email.
Frequently Asked Questions
Compare Agenus with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Agenus on 12 Sep 2024, and Merus N.V. on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.